Condensed Statements of Cash Flows (Unaudited) (USD $)	3 Months Ended
	Sep. 30, 2012	Sep. 30, 2011
Cash flows from operating activities:
Net income (loss)	$ 995,000	$ (1,208,000)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	134,000	99,000
Stock based compensation expense	143,000	366,000
Gain on sale of product line	(2,000,000)	0
Net change in operating assets and liabilities:
Accounts receivable, net	1,043,000	(447,000)
Inventories	13,000	(230,000)
Prepaid expenses and other current assets	(28,000)	105,000
Other assets	0	1,000
Accounts payable	(982,000)	29,000
Accrued payroll and related expenses	(26,000)	142,000
Deferred revenue	(15,000)	80,000
Other liabilities	(54,000)	(457,000)
Net cash used in operating activities	(777,000)	(1,520,000)
Cash flows from investing activities:
Capital expenditures	(295,000)	(36,000)
Proceeds from sale of product line	2,000,000	0
Net cash provided by (used in) investing activities	1,705,000	(36,000)
Cash flows from financing activities:
Repurchase of common stock	(54,000)	0
Net cash used in financing activities	(54,000)	0
Net increase (decrease) in cash and cash equivalents	874,000	(1,556,000)
Cash and cash equivalents at beginning of period	7,879,000	12,309,000
Cash and cash equivalents at end of period	8,753,000	10,753,000
Supplemental non-cash financing and investing information:
Transfer of inventories to equipment	$ 59,000	$ 0